SEVERE ASTHMA SERIES
Oxidative DNA damage and somatic mutations in chronic obstructive pulmonary disease
 
More details
Hide details
1
Department of Thoracic Medicine, University Hospital of Heraklion, Crete Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Greece
 
 
Corresponding author
Eleni G. Tzortzaki   

Respiratory Medicine Department of Thoracic Medicine, University Hospital of Heraklion & Medical School, University of Crete, 71110, Crete, Greece
 
 
Pneumon 2012;25(1):104-108
 
KEYWORDS
 
REFERENCES (32)
1.
Avery SV. Molecular targets of oxidative stress. Biochem J. 2011;434(2):201-10.
 
2.
Faux SP, Tai T, Thorne D, Xu Y, Breheny D, Gaca M. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers. 2009;14 Suppl 1:90-6.
 
3.
Wistuba II, Mao L, Gazdar AF. Smoking molecular damage in bronchial epithelium. Oncogene 2002;21;7298-7306.
 
4.
Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010;40:179-204.
 
5.
Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med. 2005; 4(3):175-200.
 
6.
Loukides S, Bakakos P, Kostikas K. Oxidative Stress in Patients with COPD. Curr Drug Targets. 2011 Apr 1;12(4):469-77.
 
7.
Chung KF, Marwick JA. Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci. 2010;1203:85-91.
 
8.
Boyer JC, Yamada NA, Roques CN, Hatch SB, Riess K, Farber RA. Sequence dependent instability of mononucleotide microsatellites in cultured mismatch repair proficient and deficient mammalian cells. Hum Mol Genet. 2002 Mar 15;11(6):707-13.
 
9.
Anderson GP, Bozinovski S. Acquired somatic mutations in the molecular pathogenesis of COPD. Trends Pharmacol Sci 2003;24:71-76.
 
10.
Campbell NA, Reece JB. 2008. Biology (8th Edition). San Francisco (CA): Pearson Benjamin Cummings Publishing Co.
 
11.
Richard GF, Kerrest A, Dujon B. Comparative genomics and molecular dynamics of DNA repeats in Eukaryotes. Micr Mol Bio Rev 2008; 72:686-727.
 
12.
Li YC, Korol AB, Fahima T et al. Microsatellites: genomic distribution, putative functions and mutational mechanisms: a review. Mol Ecol 2002; 11:2453-2465.
 
13.
Li YC, Korol AB, Fahima T et al. Microsatellites within genes: structure, function and evolution. Mol Bio Evol 2003; 21:991-1007.
 
14.
Iyer R, Pluciennik A, Burdett V, Modrich P. DNA mismatch repair: functions and mechanisms. Chem Rev 2006; 106:302–23.
 
15.
Ljungman M. The DNA Damage Response-Repair or Despair? Environmental and Molecular Mutagenesis 2010; DOI 10.1002/ em.20597.
 
16.
Spandidos DA, Ergazaki M, Hatzistamou J et al. Microsatellite DNA Instability in patients with Chronic Obstructive Pulmonary Disease. Oncol Rep 1996; 3:489-491.
 
17.
Siafakas NM, Tzortzaki EG, Sourvinos G et al. Microsatellite DNA instability in COPD. Chest. 1999;116:47-51.
 
18.
Paraskakis E, Sourvinos G, Passam F et al. Microsatellite DNA Instability and Loss of Heterozygosity in Bronchial Asthma. Eur. Respir. J. 2003; 22(6):951-5.
 
19.
Zervou MI, Tzortzaki EG, Makris D et al. Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease. Eur Respir J 2006;28:472-478.
 
20.
Makris D, Tzanakis N, Damianaki A, et al. Microsatellite DNA instability and COPD exacerbations. Eur Respir J 2008 ;32:612-8.
 
21.
Samara KD, Tzortzaki EG, Neofytou E, et al. Somatic DNA alterations in lung epithelial barrier cells in COPD patients. Pulm Pharmacol Ther 2010; 23:208-214.
 
22.
Tzortzaki EG, Siafakas NM. A hypothesis for the initiation of COPD. Eur Respir J 2009; 34:310-315.
 
23.
Tsoumakidou M, Koutsopoulos AV, Tzanakis N, Tzortzaki E, Siafakas N. Decreased Small Airway and Alveolar CD83+ Dendritic Cells in Chronic Obstructive Pulmonary Disease. Chest 2009; 136:726-33.
 
24.
Matzinger P. The danger model: a renewed sense of self. Science 2002; 296:301-5.
 
25.
Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360:2445-54.
 
26.
Chrysofakis G, Siafakas N, Tsoumakidou M, et al. Expression of perforin and cytotoxic activity of CD8+ cells in induced sputum from current smokers with COPD. Pneumon 2002, 15:63-73.
 
27.
Kuwano K. Epithelial cell apoptosis and lung remodeling. Cell Mol Immunol 2007; 4:419-29.
 
28.
Plataki M, Tzortzaki E, RytilaP, Makris D, KoutsopoulosA, SiafakasNM. Apoptotic mechanisms in the pathogenesis of COPD. Intern J of COPD 2006;1:161-171.
 
29.
Rovina N. The role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Pneumon 2008; 21:68–76.
 
30.
Siganaki M, Koutsopoulos AV, Neofytou E, et al. Deregulation of apoptosis mediators’ p53 and bcl2 in lung tissue of COPD patients. Respir Res. 2010;11:46.
 
31.
Vlachaki E, Koutsopoulos AV, Tzanakis N, et al. Altered Surfactant protein-A (SP-A) expression in type II Pneumocytes in COPD. Chest 2010; 137:37-45.
 
32.
Tzortzaki E, Vlachaki E, Siafakas NM. Pulmonary Surfactant. Pneumon 2007; 20:364–371.
 
eISSN:1791-4914
ISSN:1105-848X
Journals System - logo
Scroll to top